Federated Hermes, Inc. Minerva Neurosciences, Inc. Transaction History
Federated Hermes, Inc.
- $43.6 Billion
- Q3 2024
A detailed history of Federated Hermes, Inc. transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,351,275 shares of NERV stock, worth $3.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,351,275
Previous 1,351,275
-0.0%
Holding current value
$3.12 Million
Previous $4.31 Million
16.31%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NERV
# of Institutions
20Shares Held
2.09MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA252KShares$582,2580.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$363,1320.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL99.9KShares$230,6670.02% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$167,8650.0% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$130,4130.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $12.3M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...